Loss of HB-EGF in smooth muscle or endothelial cell lineages causes heart malformation

被引：17
作者：
Nanba, Daisuke
Kinugasa, Yumi
Morimoto, Chie
Koizumi, Michiko
Yamamura, Hisako
Takahashi, Katsuhito
Takakura, Nobuyuki
Mekada, Eisuke
Hashimoto, Koji
Higashiyama, Shigeki [1 ]
机构：
[1] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan
[2] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Med, Osaka 5378511, Japan
[4] Osaka Univ, Res Inst Microbial Dis, Dept Signal Transduct, Osaka 5650871, Japan
[5] Osaka Univ, Res Inst Microbial Dis, Dept Cell Biol, Osaka 5650871, Japan
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2006年 / 350卷 / 02期
关键词：
cardiac hypertrophy; conditional knockout; HB-EGF; heart valves; heart failure;
D O I：
10.1016/j.bbrc.2006.09.060
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Epidermal growth factor (EGF) and ErbB family molecules play a role in heart development and function. To investigate the role of EGF family member, heparin-binding EGF-like growth factor (HB-EGF) in heart development, smooth muscle and endothelial cell lineage-specific HB-EGF knockout mice were generated using the Cre/loxP system in combination with the SM22 alpha or TIE2 promoter. HBEGF knockout mice displayed enlarged heart valves, and over half of these mice died during the first postnatal week, while survivors showed cardiac hypertrophy. These results suggest that expression of HB-EGF in smooth muscle and/or endothelial cell lineages is essential for proper heart development and function in mice. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码：315 / 321
页数：7
相关论文
共 32 条
[1]   Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy [J].
Asakura, M ;
Kitakaze, M ;
Takashima, S ;
Liao, Y ;
Ishikura, F ;
Yoshinaka, T ;
Ohmoto, H ;
Node, K ;
Yoshino, K ;
Ishiguro, H ;
Asanuma, H ;
Sanada, S ;
Matsumura, Y ;
Takeda, H ;
Beppu, S ;
Tada, M ;
Hori, M ;
Higashiyama, S .
NATURE MEDICINE, 2002, 8 (01) :35-40
[2]   Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis [J].
Chen, BB ;
Bronson, RT ;
Klaman, LD ;
Hampton, TG ;
Wang, JF ;
Green, PJ ;
Magnuson, T ;
Douglas, PS ;
Morgan, JP ;
Neel, BG .
NATURE GENETICS, 2000, 24 (03) :296-299
[3]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[4]   Lineage and morphogenetic analysis of the cardiac valves [J].
de Lange, FJ ;
Moorman, AFM ;
Anderson, RH ;
Männer, J ;
Soufan, AT ;
de Vries, CD ;
Schneider, MD ;
Webb, S ;
van den Hoff, MJB ;
Christoffels, VM .
CIRCULATION RESEARCH, 2004, 95 (06) :645-654
[5]   CALPONIN AND SM22 AS DIFFERENTIATION MARKERS OF SMOOTH-MUSCLE - SPATIOTEMPORAL DISTRIBUTION DURING AVIAN EMBRYONIC-DEVELOPMENT [J].
DUBAND, JL ;
GIMONA, M ;
SCATENA, M ;
SARTORE, S ;
SMALL, JV .
DIFFERENTIATION, 1993, 55 (01) :1-11
[6]   ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk [J].
Higashiyama, S ;
Nanba, D .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1751 (01) :110-117
[7]   A HEPARIN-BINDING GROWTH-FACTOR SECRETED BY MACROPHAGE-LIKE CELLS THAT IS RELATED TO EGF [J].
HIGASHIYAMA, S ;
ABRAHAM, JA ;
MILLER, J ;
FIDDES, JC ;
KLAGSBRUN, M .
SCIENCE, 1991, 251 (4996) :936-939
[8]  
HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205
[9]   Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure [J].
Holtwick, R ;
Gotthardt, M ;
Skryabin, B ;
Steinmetz, M ;
Potthast, R ;
Zetsche, B ;
Hammer, RE ;
Herz, J ;
Kuhn, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :7142-7147
[10]   Heparin-binding EGF-like growth factor: a juxtacrine growth factor [J].
Iwamoto, R ;
Mekada, E .
CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (04) :335-344
1234